Kura Oncology (KURA) Interest Coverage Ratio Growth (1y) (2011 - 2026)
Kura Oncology (KURA) Interest Coverage Ratio Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -60.44% |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -347.04% |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 787.12% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 53.59% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -32.04% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 73.00% |
| 10 | Kura Oncology | 928.19 Mn | 928.19 Mn | 18.00 Mn | 93.83% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 93.83% |
| Dec 31, 2025 | -147.91% |
| Sep 30, 2025 | -12.35% |
| Jun 30, 2025 | 98.37% |
| Mar 31, 2025 | -64.97% |
| Dec 31, 2014 | 94.57% |
| Sep 30, 2014 | -6.46% |
| Jun 30, 2014 | 24.48% |
| Mar 31, 2014 | 32.25% |
| Dec 31, 2013 | 25.34% |
| Sep 30, 2013 | 26.91% |
| Jun 30, 2013 | -7.43% |
| Mar 31, 2013 | -0.05% |
| Dec 31, 2012 | 25.85% |
| Sep 30, 2012 | 37.74% |
| Jun 30, 2012 | 39.57% |
| Mar 31, 2012 | 21.95% |
| Dec 31, 2011 | 35.22% |
| Sep 30, 2011 | 26.23% |